The ROE as of October 2024 (TTM) for LianBio (LIAN) is -31.46%

According to LianBio’s latest financial reports and current stock price. The company's current ROE is -31.46%. This represents a change of 225.53% compared to the average of -9.66% of the last 4 quarters.

LianBio (LIAN) Historical ROE (quarterly & annually)

How has LIAN ROE performed in the past?

The mean historical ROE of LianBio over the last ten years is 40.31%. The current -31.46% ROE has changed -178.04% with respect to the historical average. Over the past ten years (40 quarters), LIAN's ROE was at its highest in in the June 2021 quarter at 34.44%. The ROE was at its lowest in in the June 2022 quarter at -14.50%.

LianBio (LIAN) ROE by Quarter and Year

Discovering the peaks and valleys of LianBio ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

LianBio (LIAN) Average ROE

How has LIAN ROE performed in the past?

The current ROE of LianBio (LIAN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

LianBio (LIAN) ROE vs. Peers

How is LIAN’s ROE compared to its peers?

LianBio’s ROE is greater than Sensei Biotherapeutics, Inc. (-48.14%), greater than NextCure, Inc. (-57.63%), greater than Nuvation Bio Inc. (-98.79%), greater than Graphite Bio, Inc. (-57.96%), greater than Merrimack Pharmaceuticals, Inc. (-35.28%), greater than Inozyme Pharma, Inc. (-68.93%), greater than Day One Biopharmaceuticals, Inc. (-22.40%), greater than Terns Pharmaceuticals, Inc. (-39.58%), greater than Eledon Pharmaceuticals, Inc. (-124.74%), greater than HOOKIPA Pharma Inc. (-51.77%), greater than Fennec Pharmaceuticals Inc. (-52.10%), greater than Larimar Therapeutics, Inc. (-35.87%), greater than Verrica Pharmaceuticals Inc. (-691.62%), greater than Homology Medicines, Inc. (-100.91%), greater than Neoleukin Therapeutics, Inc. (-47.64%), greater than Instil Bio, Inc. (-55.57%), greater than Achilles Therapeutics plc (-47.36%), greater than Assembly Biosciences, Inc. (-121.55%), greater than Acumen Pharmaceuticals, Inc. (-24.63%),

Build a custom stock screener for LianBio (LIAN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LianBio using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

LianBio (LIAN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like LianBio or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.